OZEM holdings
Roundhill GLP-1 & Weight Loss ETF
Positions
26 stored of 26 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Novo Nordisk A/S | US6701002056 | 670100205 | 12.963% | $7.0M | Equity (common) | Corporate | Denmark | USD |
| 2 | Eli Lilly & Co | US5324571083 | 532457108 | 12.691% | $6.9M | Equity (common) | Corporate | United States | USD |
| 3 | Mount Vernon Liquid Assets Portfolio, LLC | Not reported | Not reported | 9.933% | $5.4M | Short-term investment vehicles (cash funds) | Private fund | United States | USD |
| 4 | Pfizer Inc | US7170811035 | 717081103 | 6.385% | $3.5M | Equity (common) | Corporate | United States | USD |
| 5 | Kailera Therapeutics Inc | US4829311020 | 482931102 | 6.212% | $3.4M | Equity (common) | Corporate | United States | USD |
| 6 | Viking Therapeutics Inc | US92686J1060 | 92686J106 | 5.856% | $3.2M | Equity (common) | Corporate | United States | USD |
| 7 | CSPC Pharmaceutical Group Ltd | HK1093012172 | Not reported | 5.318% | $2.9M | Equity (common) | Corporate | China | HKD |
| 8 | Chugai Pharmaceutical Co Ltd | JP3519400000 | Not reported | 4.509% | $2.4M | Equity (common) | Corporate | Japan | JPY |
| 9 | Ascletis Pharma Inc | KYG0520K1094 | Not reported | 4.198% | $2.3M | Equity (common) | Corporate | China | HKD |
| 10 | Zealand Pharma A/S | DK0060257814 | Not reported | 3.921% | $2.1M | Equity (common) | Corporate | Denmark | DKK |
| 11 | Amgen Inc | US0311621009 | 031162100 | 3.850% | $2.1M | Equity (common) | Corporate | United States | USD |
| 12 | AstraZeneca PLC | GB0009895292 | Not reported | 3.833% | $2.1M | Equity (common) | Corporate | United Kingdom | USD |
| 13 | Hanmi Pharm Co Ltd | KR7128940004 | Not reported | 3.504% | $1.9M | Equity (common) | Corporate | South Korea | KRW |
| 14 | Structure Therapeutics Inc | US86366E1064 | 86366E106 | 3.054% | $1.7M | Equity (common) | Corporate | United States | USD |
| 15 | Roche Holding AG | CH1499059983 | Not reported | 3.030% | $1.6M | Equity (common) | Corporate | Switzerland | CHF |
| 16 | MBX Biosciences Inc | US55287L1017 | 55287L101 | 2.799% | $1.5M | Equity (common) | Corporate | United States | USD |
| 17 | UNITED LAB United Laboratories International Holdings Ltd/The | KYG8813K1085 | Not reported | 2.628% | $1.4M | Equity (common) | Corporate | Hong Kong | HKD |
| 18 | Jiangsu Hengrui Pharmaceutical Jiangsu Hengrui Pharmaceuticals Co Ltd | CNE100006XS6 | Not reported | 2.581% | $1.4M | Equity (common) | Corporate | China | HKD |
| 19 | Hansoh Pharmaceutical Group Co Hansoh Pharmaceutical Group Co Ltd | KYG549581067 | Not reported | 2.542% | $1.4M | Equity (common) | Corporate | China | HKD |
| 20 | Innovent Biologics Inc | KYG4818G1010 | Not reported | 2.365% | $1.3M | Equity (common) | Corporate | China | HKD |
| 21 | Gubra A/S | DK0062266474 | Not reported | 1.875% | $1.0M | Equity (common) | Corporate | Denmark | DKK |
| 22 | Gilead Sciences Inc | US3755581036 | 375558103 | 1.735% | $938K | Equity (common) | Corporate | United States | USD |
| 23 | Rhythm Pharmaceuticals Inc | US76243J1051 | 76243J105 | 1.636% | $884K | Equity (common) | Corporate | United States | USD |
| 24 | Shionogi & Co Ltd | JP3347200002 | Not reported | 1.241% | $671K | Equity (common) | Corporate | Japan | JPY |
| 25 | WaVe Life Sciences Ltd | SG9999014716 | Not reported | 0.864% | $467K | Equity (common) | Corporate | Singapore | USD |
| 26 | First American Government Obli First American Government Obligations Fund | US31846V3362 | 31846V336 | 0.619% | $335K | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |